Advancements in risk stratification and management strategies in primary cardiovascular prevention

By sjmartinez • June 3, 2024

Barkas F, Sener YZ, Golforoush PA, Kheirkhah A, Rodriguez-Sanchez E, Novak J, Apellaniz-Ruiz M, Akyea RK, Bianconi V, Ceasovschih A, Chee YJ, Cherska M, Chora JR, D'Oria M, Demikhova N, Kocyigit Burunkaya D, Rimbert A, Macchi C, Rathod K, Roth L, Sukhorukov V, Stoica S, Scicali R, Storozhenko T, Uzokov J, Lupo MG, van der Vorst EPC, Porsch F. Advancements in risk stratification and management strategies in primary cardiovascular prevention. Atherosclerosis. 2024 May 15;395:117579. doi: 10.1016/j.atherosclerosis.2024.117579. Epub ahead of print. PMID: 38824844.

Tags: Atherosclerosis, Cardiology/Epi, cardiovascular disease, Plaque regression, Post Doc, primary prevention, Publications, Risk stratification

Efficacy and Toxicity of [177Lu]Lu-PSMA-617 for Metastatic Castration-Resistant Prostate Cancer: Results from the U.S. Expanded-Access Program and Comparisons with Phase 3 VISION Data

Murthy V, Voter AF, Nguyen K, Allen-Auerbach M, Chen L, Caputo S, Ledet E, Akerele A, Tuchayi AM, Lawhn-Heath C, Wang T, Carducci MA, Pomper[...]

Response to “Epicardial fat tissue and diastolic dysfunction in both men and women with HIV”

Goldberg RL, Peterson TE, Haberlen SA, Witt MD, Palella FJ, Magnani JW, Brown TT, Lake JE, Lima JAC, Budoff MJ, Ndumele CE, Wu KC, Post[...]

Comparative analysis of two independent Myh6-Cre transgenic mouse lines

Davenport A, Kessinger CW, Pfeiffer RD, Shah N, Xu R, Abel ED, Tucker NR, Lin Z. Comparative analysis of two independent Myh6-Cre transgenic mouse lines.[...]